Form 4: Novavax Director Gregg Alton Exercises Restricted Stock Units, Increases Common Stock Holdings
Insider Transaction Report
Novavax Inc. Director Gregg H. Alton has exercised 10,420 Restricted Stock Units, converting them into common stock and increasing his direct beneficial ownership to 28,805 shares.
Summary
- Gregg H. Alton, a Director at Novavax Inc. (NVAX), completed a transaction on June 12, 2025.
- The transaction involved the exercise of 10,420 Restricted Stock Units (RSUs).
- These RSUs were converted into 10,420 shares of Novavax common stock at an exercise price of $0.
- Following this transaction, Mr. Alton's direct beneficial ownership of Novavax common stock increased to 28,805 shares.
- The number of derivative securities (RSUs) beneficially owned by Mr. Alton after this transaction is now 0.
Sentiment
Score: 6
Explanation: The sentiment is slightly positive as a director is converting equity compensation into direct share ownership, which aligns their interests with shareholders. However, it's a routine transaction and not indicative of significant new information.
Positives
- A director exercising Restricted Stock Units indicates a conversion of equity compensation into direct share ownership, aligning their interests with shareholders.
- The increase in direct beneficial ownership of common stock by a director can be viewed as a positive signal of confidence in the company's future.
Future Outlook
This Form 4 filing does not provide any forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This filing reports a routine insider transaction and does not provide broader industry context or trends.
Stakeholder Impact
- Shareholders: The exercise of Restricted Stock Units by a director and the resulting increase in their direct common stock ownership can be seen as a positive alignment of interests with shareholders.
Key Dates
| Date | Description |
|---|---|
| 06/12/2025 | Date of transaction, exercise of Restricted Stock Units, and date RSUs became exercisable and expire. |
| 06/16/2025 | Date the Form 4 was signed and filed. |
Keywords
Novavax, NVAX, SEC Form 4, Insider Transaction, Stock Ownership, Restricted Stock Units, RSU Exercise, Director Holdings, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.